# Sermorelin / GHRP-6 / GHRP-2 Blend

> This blend adds GHRP-6, a ghrelin-receptor agonist known for pronounced appetite stimulation, to the sermorelin/GHRP-2 combination. It is discussed mainly in the context of protocols emphasizing both GH release and increased caloric intake, such as informal mass-gain research. Because GHRP-6 and GHRP-2 both act at the ghrelin receptor, combining them targets an overlapping pathway rather than two distinct mechanisms, and the added benefit of using both together over either alone has not been directly studied. Sermorelin and GHRP-2 individually carry a longer research history; GHRP-6's appetite-driving properties are well documented, but the specific triple combination has limited dedicated research. It is not approved for human medical use.

- URL: https://www.lifeconverted.com/peptides/sermorelin-ghrp6-ghrp2-blend
- Also known as: Triple Secretagogue Blend
- Primary category: GH Blends
- Effectiveness rank: #999 in Growth Hormone Peptides; #999 in GH Releasing Hormones; #5 in GH Blends
- Evidence level: Moderate evidence
- Route: Subcutaneous (Injected subcutaneously, generally 2-3 times daily; the pronounced appetite effect of GHRP-6 leads many protocols to time doses around meals.)
- Dose range: 300-700 mcg
- Dose tiers: low 300 mcg; moderate 450 mcg; high 700 mcg
- Half-life: All three components are short-acting: sermorelin at roughly 10-20 minutes, GHRP-6 and GHRP-2 both at roughly 30-60 minutes, requiring multiple daily doses.
- Timing: ~30 min before bed, empty stomach
- Cycle: 8-12 weeks on, 4 weeks off (The pronounced appetite effect is often used as a practical cue for meal timing rather than a reason to shorten the cycle.)
- Storage: Refrigerate after reconstitution (2-8°C); commonly described as stable for 2-3 weeks.

## Mechanism of action

Sermorelin stimulates the GHRH receptor as described for the sermorelin/GHRP-2 pairing. GHRP-6 and GHRP-2 both act at the ghrelin receptor (GHS-R1a); GHRP-6 is particularly associated with hypothalamic ghrelin-receptor activity that drives pronounced appetite stimulation, layered here alongside GHRP-2's GH-pulse effect. Proponents describe the combination as intensifying total ghrelin-receptor activation and appetite drive alongside GHRH-receptor stimulation, though this redundancy has not been formally compared with either GHRP used alone.

## Reported benefits

- Stimulates a strong growth-hormone pulse
- Associated with pronounced appetite stimulation, useful in mass-gain-oriented research contexts
- Supports recovery
- Reported to support sleep quality

## Reported side effects

- Pronounced increase in hunger
- Water retention
- Flushing
- Lethargy
- Injection site irritation

## Common protocols

- Mass Gain Stack
- Appetite & Recovery Protocol

## Stacking notes

Combining two ghrelin-receptor agonists (GHRP-6 and GHRP-2) is mechanistically redundant; proponents cite intensified appetite and GH response, though this has not been directly compared with either GHRP alone in controlled research.

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer